Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 16/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 11/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 7/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 7/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 7/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 7/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 7/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 7/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3788122 | 1.00 | HDAC1 (0.62) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL3782474 | 1.00 | HDAC1 (0.62) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2928291 | 0.94 | HDAC1 (0.53) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2928043 | 0.94 | HDAC1 (0.53) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL3783833 | 0.90 | HDAC6 (0.60) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2925486 | 0.82 | HDAC1 (0.69) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2930569 | 0.82 | HDAC1 (0.80) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2929637 | 0.81 | HDAC1 (0.84) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2926697 | 0.81 | HDAC1 (0.84) | HDAC1HDAC6HDAC3HDAC8HDAC4 | |
| SCHEMBL2926696 | 0.81 | HDAC1 (0.84) | HDAC1HDAC6HDAC3HDAC8HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231623-B1 | 5-PHENYL-1H-BENZO[E][1, 4]DIAZEPINE COMPOUNDS SUBSTITUTED WITH AN HYDROXAMIC ACID GROUP AS HISTONE DEACETYLASE INHIBITORS | UNIV FIRENZE (IT) | 2013-05-22 | — | — | EP | disclosed |
| US-8324202-B2 | 5-phenyl-1H-benzo [E] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors | UNIVERSITA DEGLI STUDI DI FIRENZE (IT) | 2012-12-04 | — | — | US | disclosed |
| US-20100331316-A1 | 5-PHENYL-LH-BENZ0 [E] [1,4] DIAZEPINE COMPOUNDS SUBSTITUTED WITH AN HYDROXAMIC ACID GROUP AS HISTONE DEACETYLASE INHIBITORS | A.I.L. FIRENZE SEZIONE AUTONOMA DI FIRENZE DELL'ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE, LINFOMI E MIELOMA - ONLUS (IT) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331316-A1 | 5-PHENYL-LH-BENZ0 [E] [1,4] DIAZEPINE COMPOUNDS SUBSTITUTED WITH AN HYDROXAMIC ACID GROUP AS HISTONE DEACETYLASE INHIBITORS | HDAC10, HDAC1, HDAC5 | HDAC1 2/4885HDAC6 13/4885HDAC3 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.